Metal polyphenol nano-enzyme as well as preparation method and application thereof
By constructing a core-shell structured metal polyphenol nanozyme and utilizing Ce-TA co-loaded with RSV and a hybrid cell membrane, the problems of poor targeting, immune escape, and release controllability in existing technologies have been solved, achieving a highly efficient and safe treatment for inflammatory bowel disease.
Patent Information
- Application Number
- CN202511906071.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-17
- Publication Date
- 2026-03-17
AI Technical Summary
Existing technologies for treating inflammatory bowel disease (IBD) suffer from limitations in targeting, insufficient immune escape, limited catalytic activity, and poor release controllability, resulting in low drug delivery efficiency, high toxicity risk, and difficulty in achieving drug concentrations at the lesion site.
The metal polyphenol nanozyme with a core-shell structure has a core of Ce-TA and RSV co-loaded nanoparticles and a shell of hybrid macrophage and neutrophil membranes. It utilizes Ce3+/Ce4+ valence state cycling and pH/ROS dual response release characteristics to achieve SOD-CAT cascade ROS clearance and RSV anti-inflammatory synergy, cross the mucus layer and epithelial barrier, prolong the circulating half-life and achieve controlled release.
It significantly enhances catalytic activity and targeting ability, prolongs drug circulation time in vivo, increases lesion enrichment, reduces toxicity risk, and achieves precise and controllable drug release at the site of inflammation, avoiding off-target toxicity.